Dr. Molholm and colleagues suggested that electroencephalogram (EEG) recordings could potentially reveal the autism severity in individuals affected by autism. The study found that children with autism process sensory information less rapidly than typically developing children do.
Some children can 'recover' from autism, but problems often remain, study finds
Research in the past several years has shown that children can outgrow a diagnosis of autism spectrum disorder, once considered a lifelong condition. In a new study, researchers have found that the vast majority of such children still have difficulties that require therapeutic and educational support.
Potential role of cerebellum in social functioning and autism
Dr. Khodakhah and colleagues at Albert Einstein College of Medicine spublished a study in the journal of Scuggests that social behavior requires a functioning cerebellum-VTA pathway and that interference with this pathway may be a glitch through which cerebellar dysfunction contributes to autism.
Einstein has received a five-year, $5 million grant from the National Institutes of Health (NIH) to support the IDD research. The funding will sustain and deepen collaborations between Einstein scientists and clinicians at Montefiore aimed at improving the care and treatment of children with IDD.
Promising treatments for autism are being tested at Einstein and Montefiore
Dr. Eric Hollander and colleagues are investigating potential therapies to the rigor of solid scientific research to inform parents and clinicians about the therapies’ usefulness. From cannabis to whipworms, scientifically promising treatments for autism are being tested at Einstein and Montefiore.
ICARE4Autism meeting has gathered a diverse community of autism professionals at Einstein
The ICare4Autism Conference was held at Einstein with a diverse community of professionals. The goal of the meeting was to increase awareness, knowledge of medical & educational research findings, clinical best-practices, inform policymakers, and empower people with autism and their family members.
Recent finding can help identifying therapeutic targets for syndromic autism
The group of Dr. Bryen Jordan has recently characterized a novel genetic disorder that can lead to autism. The group has identified patients harboring monogenic deletions of the ANKS1B gene. Affected individuals present with a spectrum of neurodevelopmental phenotypes, including autism and speech and motor deficits.